SCHEMBL22889192

SCHEMBL22889192

c1cc(-c2ccc3ccccc3c2)cc(-c2nc(-c3cccc(-c4ccc5ccccc5c4)c3)nc(-c3cccc4c3sc3ccccc34)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.48
S1PR5 Q9H228 8/20 0.38
S1PR4 O95977 6/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
PARP14 Q460N5 1/20 0.37
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MAPT P10636 1/20 0.36
PRKDC P78527 3/20 0.35
PIM1 P11309 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21304427 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304680 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL27252323 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304555 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304563 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304425 0.97 ALOX5 (0.46) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304554 0.96 ALOX5 (0.45) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL22888840 0.96 ALOX5 (0.48) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304904 0.96 ALOX5 (0.45) ALOX5S1PR5S1PR4HSD17B1HSD17B2
SCHEMBL21304415 0.96 ALOX5 (0.45) ALOX5S1PR5S1PR4HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885S1PR5 4056/4885S1PR4 2224/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885S1PR5 4057/4885S1PR4 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.